Patents by Inventor Keith N. Haffer

Keith N. Haffer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11400151
    Abstract: A method is provided for increasing an immunological response to a target antigen in an animal by administering an immunogenic amount of a vaccine comprising a polypeptide conjugate comprising the target antigen conjugated to a carrier polypeptide by means of a linker polypeptide which is rich in predicted linear B-cell epitopes.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: August 2, 2022
    Assignee: Braasch Biotech LLC
    Inventor: Keith N. Haffer
  • Publication number: 20190374634
    Abstract: A method is provided for increasing an immunological response to a target antigen in an animal by administering an immunogenic amount of a vaccine comprising a polypeptide conjugate comprising the target antigen conjugated to a carrier polypeptide by means of a linker polypeptide which is rich in predicted linear B-cell epitopes.
    Type: Application
    Filed: August 27, 2019
    Publication date: December 12, 2019
    Inventor: Keith N. Haffer
  • Patent number: 10441652
    Abstract: A method is provided for increasing an immunological response to a target antigen in an animal by administering an immunogenic amount of a vaccine comprising a polypeptide conjugate comprising the target antigen conjugated to a carrier polypeptide by means of a linker polypeptide which is rich in predicted linear B-cell epitopes.
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: October 15, 2019
    Assignee: Braasch Biotech LLC
    Inventor: Keith N. Haffer
  • Publication number: 20160051668
    Abstract: A method is provided for increasing an immunological response to a target antigen in an animal by administering an immunogenic amount of a vaccine comprising a polypeptide conjugate comprising the target antigen conjugated to a carrier polypeptide by means of a linker polypeptide which is rich in predicted linear B-cell epitopes.
    Type: Application
    Filed: August 20, 2015
    Publication date: February 25, 2016
    Inventor: Keith N. Haffer
  • Patent number: 8425914
    Abstract: Compositions and methods are provided for treatment growth hormone and/or insulin-like growth factor 1 deficiency in a patient in need of such treatment. Compositions and methods include novel vaccines that provide immunogenicity for somatostatin and result in the increased release of endogenously produced growth hormone and/or insulin-like growth factor 1.
    Type: Grant
    Filed: June 24, 2009
    Date of Patent: April 23, 2013
    Assignee: Braasch Biotech LLC
    Inventors: Keith N. Haffer, James Larrick, Andrew R. Mendelsohn
  • Patent number: 8367073
    Abstract: Chimeric somatostatin-based polypeptides, polynucleotides used to encode the polypeptides, the methods for isolating and producing the polypeptides and the uses thereof are provided. In addition, low cost adjuvants for enhanced immunogenic response are provided. Vaccinations that include both chimeric somatostatin-based polypeptides and novel adjuvants are included, useful in facilitating farm animal productivity.
    Type: Grant
    Filed: March 23, 2011
    Date of Patent: February 5, 2013
    Assignee: Braasch Biotech, LLC
    Inventors: Andrew R. Mendelsohn, Keith N. Haffer, James Larrick
  • Publication number: 20120076806
    Abstract: Chimeric somatostatin-based polypeptides, polynucleotides used to encode the polypeptides, the methods for isolating and producing the polypeptides and the uses thereof are provided. In addition, low cost adjuvants for enhanced immunogenic response are provided. Vaccinations that include both chimeric somatostatin-based polypeptides and novel adjuvants are included, useful in facilitating farm animal productivity.
    Type: Application
    Filed: March 23, 2011
    Publication date: March 29, 2012
    Applicant: BRAASCH BIOTECH LLC
    Inventors: Andrew R. Mendelsohn, Keith N. Haffer, James Larrick
  • Publication number: 20110195080
    Abstract: Compositions and methods are provided for treatment growth hormone and/or insulin-like growth factor 1 deficiency in a patient in need of such treatment. Compositions and methods include novel vaccines that provide immunogenicity for somatostatin and result in the increased release of endogenously produced growth hormone and/or insulin-like growth factor 1.
    Type: Application
    Filed: June 24, 2009
    Publication date: August 11, 2011
    Applicant: BRAASCH BIOTECH LLC
    Inventors: Keith N. Haffer, James Larrick, Andrew R. Mendelsohn
  • Patent number: 7943143
    Abstract: Chimeric somatostatin-based polypeptides, polynucleotides used to encode the polypeptides, the methods for isolating and producing the polypeptides and the uses thereof are provided. In addition, low cost adjuvants for enhanced immunogenic response are provided. Vaccinations that include both chimeric somatostatin-based polypeptides and novel adjuvants are included, useful in facilitating farm animal productivity.
    Type: Grant
    Filed: February 10, 2010
    Date of Patent: May 17, 2011
    Assignee: Braasch Biotech LLC
    Inventors: Andrew R. Mendelsohn, Keith N. Haffer, James Larrick
  • Publication number: 20100136037
    Abstract: Chimeric somatostatin-based polypeptides, polynucleotides used to encode the polypeptides, the methods for isolating and producing the polypeptides and the uses thereof are provided. In addition, low cost adjuvants for enhanced immunogenic response are provided. Vaccinations that include both chimeric somatostatin-based polypeptides and novel adjuvants are included, useful in facilitating farm animal productivity.
    Type: Application
    Filed: February 10, 2010
    Publication date: June 3, 2010
    Applicant: BRAASCH BIOTECH LLC
    Inventors: Andrew R. Mendelsohn, Keith N. Haffer, James Larrick
  • Patent number: 7722881
    Abstract: Chimeric somatostatin-based polypeptides, polynucleotides used to encode the polypeptides, the methods for isolating and producing the polypeptides and the uses thereof are provided. In addition, low cost adjuvants for enhanced immunogenic response are provided. Vaccinations that include both chimeric somatostatin-based polypeptides and novel adjuvants are included, useful in facilitating farm animal productivity.
    Type: Grant
    Filed: August 26, 2008
    Date of Patent: May 25, 2010
    Assignee: Braasch Biotech LLC
    Inventors: Andrew R. Mendelsohn, Keith N. Haffer, James Larrick
  • Publication number: 20090324629
    Abstract: Chimeric somatostatin-based polypeptides, polynucleotides used to encode the polypeptides, the methods for isolating and producing the polypeptides and the uses thereof are provided. In addition, low cost adjuvants for enhanced immunogenic response are provided. Vaccinations that include both chimeric somatostatin-based polypeptides and novel adjuvants are included, useful in facilitating farm animal productivity.
    Type: Application
    Filed: August 26, 2008
    Publication date: December 31, 2009
    Applicant: BRAASCH BIOTECH LLC
    Inventors: Andrew R. Mendelsohn, Keith N. Haffer, James Larrick